Eli Lilly and Company $LLY Deep Dive

The drug maker has been on a high with their weight loss drug, but has been consolidating

Executive Summary:

Eli Lilly and Company is a global pharmaceutical company. The company is dedicated to discovering and developing life-changing medicines, focusing on areas like diabetes, oncology, immunology, and neuroscience. Lilly has gained increased attention for its advancements in treatments for conditions like diabetes and obesity. Eli Lilly also emphasizes corporate responsibility, focusing on improving access to medicines and minimizing its environmental impact.

Eli Lilly and Company reported worldwide revenue of $13.53 billion, a 45% increase compared to Q4 2023. Reported earnings per share (EPS) were $4.88, while non-GAAP EPS reached $5.32.